Publication
The senotherapeutic potential of phytochemicals for age-related intestinal disease
| dc.contributor.author | Costa, Célia Maria | |
| dc.contributor.author | Pedrosa, Sílvia Santos | |
| dc.contributor.author | Kirkland, James L | |
| dc.contributor.author | Reis, Flávio | |
| dc.contributor.author | Madureira, Raquel | |
| dc.date.accessioned | 2024-12-09T14:42:51Z | |
| dc.date.available | 2024-12-09T14:42:51Z | |
| dc.date.issued | 2025-02-01 | |
| dc.description.abstract | During the last few decades, life expectancy has increased worldwide along with the prevalence of several age-related diseases. Among aging pathways, cellular senescence and chronic inflammation (or “inflammaging”) appear to be connected to gut homeostasis and dysbiosis of the microbiome. Cellular senescence is a state of essentially irreversible cell cycle arrest that occurs in response to stress. Although senescent cells (SC) remain metabolically active, they do not proliferate and can secrete inflammatory and other factors comprising the senescence-associated secretory phenotype (SASP). Accumulation of SCs has been linked to onset of several age-related diseases, in the brain, bones, the gastrointestinal tract, and other organs and tissues. The gut microbiome undergoes substantial changes with aging and is tightly interconnected with either successful (healthy) aging or disease. Senotherapeutic drugs are compounds that can clear senescent cells or modulate the release of SASP and hence attenuate the impact of the senescence-associated pro-inflammatory state. Phytochemicals, phenolic compounds and terpenes, which have antioxidant and anti-inflammatory activities, could also be senotherapeutic given their ability to act upon senescence-linked cellular pathways. The aim of this review is to dissect links among the gut microbiome, cellular senescence, inflammaging, and disease, as well as to explore phytochemicals as potential senotherapeutics, focusing on their interactions with gut microbiota. Coordinated targeting of these inter-related processes might unveil new strategies for promoting healthy aging. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.doi | 10.1016/j.arr.2024.102619 | pt_PT |
| dc.identifier.eid | 85211352758 | |
| dc.identifier.issn | 1568-1637 | |
| dc.identifier.pmid | 39638096 | |
| dc.identifier.uri | http://hdl.handle.net/10400.14/47463 | |
| dc.identifier.wos | 001383549300001 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt_PT |
| dc.subject | Cellular senescence | pt_PT |
| dc.subject | Gut microbiota | pt_PT |
| dc.subject | Microbiota-derived metabolites | pt_PT |
| dc.subject | Senotherapeutics | pt_PT |
| dc.subject | Phytochemicals | pt_PT |
| dc.subject | Phenolic compounds | pt_PT |
| dc.title | The senotherapeutic potential of phytochemicals for age-related intestinal disease | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.title | Ageing Research Reviews | pt_PT |
| oaire.citation.volume | 104 | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |